104 related articles for article (PubMed ID: 9211539)
1. Transcription of tal-1, a putative oncogene playing an important role in childhood T-ALL, can be shown in normal peripheral blood cells by a highly sensitive RT-PCR assay.
Anderegg B; Horstmann M; Ernst M; Kabisch H
Pediatr Hematol Oncol; 1997; 14(4):349-58. PubMed ID: 9211539
[TBL] [Abstract][Full Text] [Related]
2. Expression of tal-1 and GATA-binding proteins during human hematopoiesis.
Mouthon MA; Bernard O; Mitjavila MT; Romeo PH; Vainchenker W; Mathieu-Mahul D
Blood; 1993 Feb; 81(3):647-55. PubMed ID: 7678994
[TBL] [Abstract][Full Text] [Related]
3. Expression of TAL-1 proteins in human tissues.
Pulford K; Lecointe N; Leroy-Viard K; Jones M; Mathieu-Mahul D; Mason DY
Blood; 1995 Feb; 85(3):675-84. PubMed ID: 7833471
[TBL] [Abstract][Full Text] [Related]
4. RT/PCR detection of SIL-TAL-1 fusion mRNA in Chinese T-cell acute lymphoblastic leukemia (T-ALL).
Huang W; Kuang SQ; Huang QH; Dong S; Zhang T; Gu LJ; Ching LM; Chen SJ; Chang LC; Chen Z
Cancer Genet Cytogenet; 1995 May; 81(1):76-82. PubMed ID: 7773964
[TBL] [Abstract][Full Text] [Related]
5. A third tal-1 promoter is specifically used in human T cell leukemias.
Bernard O; Azogui O; Lecointe N; Mugneret F; Berger R; Larsen CJ; Mathieu-Mahul D
J Exp Med; 1992 Oct; 176(4):919-25. PubMed ID: 1402666
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemia.
Carlotti E; Pettenella F; Amaru R; Slater S; Lister TA; Barbui T; Basso G; Cazzaniga G; Rambaldi A; Biondi A
Br J Haematol; 2002 Sep; 118(4):1011-8. PubMed ID: 12199779
[TBL] [Abstract][Full Text] [Related]
7. Distinct DNase-I hypersensitive sites are associated with TAL-1 transcription in erythroid and T-cell lines.
Leroy-Viard K; Vinit MA; Lecointe N; Mathieu-Mahul D; Roméo PH
Blood; 1994 Dec; 84(11):3819-27. PubMed ID: 7949138
[TBL] [Abstract][Full Text] [Related]
8. tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease.
Breit TM; Beishuizen A; Ludwig WD; Mol EJ; Adriaansen HJ; van Wering ER; van Dongen JJ
Leukemia; 1993 Dec; 7(12):2004-11. PubMed ID: 8255100
[TBL] [Abstract][Full Text] [Related]
9. Measurement of SIL-TAL1 fusion gene transcripts associated with human T-cell lymphocytic leukemia by real-time reverse transcriptase-PCR.
Curry JD; Smith MT
Leuk Res; 2003 Jul; 27(7):575-82. PubMed ID: 12681356
[TBL] [Abstract][Full Text] [Related]
10. T-cell acute lymphoblastic leukemia--the associated gene SCL/tal codes for a 42-Kd nuclear phosphoprotein.
Goldfarb AN; Goueli S; Mickelson D; Greenberg JM
Blood; 1992 Dec; 80(11):2858-66. PubMed ID: 1450410
[TBL] [Abstract][Full Text] [Related]
11. TAL1 expression does not occur in the majority of T-ALL blasts.
Delabesse E; Bernard M; Meyer V; Smit L; Pulford K; Cayuela JM; Ritz J; Bourquelot P; Strominger JL; Valensi F; Macintyre EA
Br J Haematol; 1998 Jul; 102(2):449-57. PubMed ID: 9695959
[TBL] [Abstract][Full Text] [Related]
12. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.
O'Neil J; Billa M; Oikemus S; Kelliher M
Oncogene; 2001 Jun; 20(29):3897-905. PubMed ID: 11439353
[TBL] [Abstract][Full Text] [Related]
13. PCR-heteroduplex analysis of TCR gamma, delta and TAL-1 deletions in T-acute lymphoblastic leukemias: implications in the detection of minimal residual disease.
Nirmala K; Rajalekshmy KR; Raman SG; Shanta V; Rajkumar T
Leuk Res; 2002 Apr; 26(4):335-43. PubMed ID: 11839375
[TBL] [Abstract][Full Text] [Related]
14. Ectopic expression of TAL-1 protein in Ly-6E.1-htal-1 transgenic mice induces defects in B- and T-lymphoid differentiation.
Goardon N; Schuh A; Hajar I; Ma X; Jouault H; Dzierzak E; Roméo PH; Maouche-Chrétien L
Blood; 2002 Jul; 100(2):491-500. PubMed ID: 12091340
[TBL] [Abstract][Full Text] [Related]
15. SCL/Tal-1 expression in T-acute lymphoblastic leukemia: an immunohistochemical and genotypic study.
Chetty R; Pulford K; Jones M; Mathieu-Mahul D; Close P; Hussein S; Pallesen G; Ralfkiaer E; Stein H; Gatter K
Hum Pathol; 1995 Sep; 26(9):994-8. PubMed ID: 7672800
[TBL] [Abstract][Full Text] [Related]
16. T-cell acute lymphoblastic leukemia and the associated basic helix-loop-helix gene SCL/tal.
Goldfarb AN; Greenberg JM
Leuk Lymphoma; 1994 Jan; 12(3-4):157-66. PubMed ID: 8167548
[TBL] [Abstract][Full Text] [Related]
17. Erythroid-specific inhibition of the tal-1 intragenic promoter is due to binding of a repressor to a novel silencer.
Courtes C; Lecointe N; Le Cam L; Baudoin F; Sardet C; Mathieu-Mahul D
J Biol Chem; 2000 Jan; 275(2):949-58. PubMed ID: 10625632
[TBL] [Abstract][Full Text] [Related]
18. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha.
Kelliher MA; Seldin DC; Leder P
EMBO J; 1996 Oct; 15(19):5160-6. PubMed ID: 8895560
[TBL] [Abstract][Full Text] [Related]
19. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.
Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM
Cancer Res; 1996 Nov; 56(22):5113-9. PubMed ID: 8912842
[TBL] [Abstract][Full Text] [Related]
20. Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins.
Hsu HL; Cheng JT; Chen Q; Baer R
Mol Cell Biol; 1991 Jun; 11(6):3037-42. PubMed ID: 2038315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
